top of page
Green Abstract

10% of our investments are through specialised funds. 

Join us for an insightful webinar with PreComb, Europe's market leader in precision oncology, dedicated to advancing the fight against cancer.

3305340.jpg
3305340.jpg
3305340.jpg
3305340.jpg
3305340.jpg
Calm_storm.jpg

Vienna

Actively supporting early-stage digital health, life sciences, and wellbeing startup founders.

Find Out More >

Concentric.jpg

London/Copenhagen

Activist venture fund uniting disruptive European founders for global impact.

Find Out More >

Danube Labs.jpg

Vienna

Commercialising academic drug discovery programmes in Central & Eastern Europe.

Find Out More >

Danube Nero.jpg

Vienna

Globally targeting neurodegenerative diseases and comprehensive aging enhancement solutions.

Find Out More >

D2. Fund.jpg

London

Venture capital for sustainable, mission-critical B2B software in Europe, fostering long-term growth.

Find Out More >

Maki.jpg

Helsinki

Nordic venture capital fund that backs innovative startups and visionary founders to create enduring companies.

Find Out More >

Pureos.jpg

Zürich

Funds private innovative drug development focused on the next generation of biological drugs.

Find Out More >

Speedinvest.jpg

Vienna

€1 B+ European seed venture fund in deep tech, FinTech, climate and marketplaces.

Find Out More >

Verve.jpg

Zürich

European deep tech venture capital investor focused on digital, tangible and health technologies.

Find Out More >

Zero One Hundred.jpg

Bratislava/Prague

Leading seed/pre-seed investment fund in consumer, software, and deep tech, aimed at bridging Eastern Europe with MENA.

Find Out More >

Over the years, Kinled has seeded, created, invested, and partnered with a number of regulated and unregulated funds. Today we are proud to be a Founding/Limited Partner in the following 10 funds:

bottom of page